CN220025051U

CN220025051U - Arterial blood sugar monitoring device

Info

Publication number: CN220025051U
Application number: CN202321708003.1U
Authority: CN
Inventors: 王晓瑾; 莫红平; 黄春荣
Original assignee: Sun Yat Sen Memorial Hospital Sun Yat Sen University
Current assignee: Sun Yat Sen Memorial Hospital Sun Yat Sen University
Priority date: 2023-06-30
Filing date: 2023-06-30
Publication date: 2023-11-17
Anticipated expiration: 2033-06-30

Abstract

The utility model relates to an arterial blood glucose monitoring device in the technical field of medical and health instruments, which comprises a blood glucose monitor, a hemostix, a syringe, a pressure sensing device and a drip bottle, wherein the blood glucose monitor is fixedly communicated with a first catheter, one end of the first catheter, which is far away from the blood glucose monitor, is fixedly communicated with a blood sampling window, one end of the blood sampling window, which is far away from the first catheter, is detachably communicated with a second catheter, one end of the second catheter, which is far away from the blood sampling window, is fixedly communicated with a three-way valve, one end of the three-way valve, which is detachably communicated with the syringe, is fixedly communicated with a third catheter, one end of the pressure sensing device, which is far away from the three-way valve, is fixedly communicated with a stop valve, and one end of the third catheter, which is far away from the stop valve, is fixedly communicated with the drip bottle. The utility model has the effect that the blood glucose monitor monitors the blood glucose value of arterial blood of a patient more accurately.

Description

Arterial blood sugar monitoring device

Technical Field

The utility model relates to the technical field of medical and health instruments, in particular to an arterial blood sugar monitoring device.

Background

Blood glucose monitoring is an important component in diabetes management, and the results are helpful for evaluating the degree of glucose metabolic disturbance of diabetics, formulating a reasonable blood glucose reducing scheme, reflecting the effect of blood glucose reducing treatment and guiding the adjustment of the treatment scheme.

In order to facilitate monitoring of blood glucose level of a patient by a medical staff, the medical staff uses a hemostix device to collect blood of interstitial fluid or finger tip of the patient, and the medical staff usually uses a blood glucose monitoring sensor device to monitor blood glucose of interstitial fluid or finger tip of the patient, but this method is not suitable for all patients to monitor blood glucose, because factors such as tissue edema, hypothermia, hypotension, vasoactive drug application and the like commonly existing in critical patients may affect diffusion of glucose between tissue and blood, and further affect accuracy of blood glucose, so improvement is needed.

Disclosure of Invention

In order to accurately monitor blood glucose of a patient, the utility model provides an arterial blood glucose monitoring device.

The utility model provides an arterial blood sugar monitoring device, which adopts the following technical scheme:

the utility model provides an arterial blood sugar monitoring devices, includes blood glucose monitor, hemostix, syringe, pressure sensing device and dropping bottle, the fixed intercommunication of blood glucose monitor has first pipe, the blood glucose monitor is used for communicating the arterial first pipe of patient inside, the one end that blood glucose monitor was kept away from to first pipe is fixed and the intercommunication has the blood sampling window, the one end and the hemostix of blood sampling window can dismantle and communicate, the one end that first pipe was kept away from to the blood sampling window is fixed and the intercommunication has the second pipe, the one end that blood sampling window was kept away from to the second pipe is fixed and the intercommunication has the three-way valve, the one end and the syringe detachable and the intercommunication of three-way valve, the one end and the pressure sensing device that the three-way valve was kept away from to the three-way valve are fixed and the intercommunication has the third pipe, the one end that the stop valve was kept away from to the third pipe and the dropping bottle are fixed and the intercommunication.

By adopting the technical scheme, when a patient needs to monitor the blood glucose level, the medical staff monitors the blood glucose level contained in arterial blood for the patient by using the blood glucose monitor communicated with the first catheter, because the medical staff monitors arterial blood of the patient by using the blood glucose monitor, the blood glucose level of the arterial blood is monitored with higher accuracy than that of monitoring interstitial fluid or finger peripheral blood, so that the blood glucose level of arterial blood of the patient is monitored by using the blood glucose monitor more accurately;

the following steps are repeated in the treatment process: the medical staff opens the stop valve to enable normal saline of the drip bottle to be conveyed into an artery of a patient along the third catheter and mixed with arterial blood to form mixed blood, the medical staff further controls the injector to extract the mixed blood for storage, when the medical staff automatically collects blood by using the hemostix, the arterial blood automatically fills the injector to a preset position to further separate the arterial catheter, at the moment, the three-way valve is opened, the mixed blood of the injector can be conveyed back into the arterial catheter of the patient, and the stop valve and the pressing valve are opened to flush the catheter; therefore, the blood glucose monitor is detachably connected with the first catheter, so that the blood glucose of a patient can be detected regularly, and the blood glucose monitoring device is convenient.

Optionally, the blood glucose monitor includes display and inductive probe, the one end of display is fixed and the electricity is connected with inductive probe's one end, inductive probe is fixed with the protective sheath, the one end and the display fixed connection of protective sheath, the extending direction setting of inductive probe is followed to the protective sheath, the connecting cylinder is connected with to the lateral wall of protective sheath can be dismantled, connecting cylinder and first pipe intercommunication, the lateral wall screw thread setting of connecting cylinder, connecting cylinder and protective sheath threaded connection, when the screw thread extending direction screw in to connecting cylinder extreme position of connecting cylinder is followed to the protective sheath, inductive probe is located inside the first pipe.

Through adopting above-mentioned technical scheme, inductive probe's periphery is provided with the protective sheath for prevent static, protective sheath and display fixed connection, the one end of connecting tube is fixed and the intercommunication with patient's artery, and when display and inductive probe were electric, medical personnel screw in protective sheath to extreme position along the connecting tube direction, and inductive probe stretches into first pipe and with patient's arterial blood contact, realizes that blood glucose monitor and first pipe's dismantlement is fixed, consequently, has made things convenient for medical personnel to the dismouting of inductive probe to get into or withdraw from patient's artery to blood glucose monitoring.

Optionally, the display includes casing and display screen, casing and display screen fixed connection.

Through adopting above-mentioned technical scheme, when the inductive probe of blood glucose monitor monitors patient's blood sugar data, the blood sugar data of patient's current arterial blood can be shown in real time to the display, and the real-time display blood sugar data of display has made things convenient for medical personnel to carry out hypoglycemic treatment scheme to the patient.

Optionally, the protective sheath fixedly connected with baffle, baffle and the inside wall fixed connection of protective sheath, baffle and inductive probe's lateral wall fixed connection and inductive probe's one end part extend the baffle.

Through adopting above-mentioned technical scheme, when inductive probe stretches into first pipe, the baffle can block arterial blood in the junction of protective sheath and baffle, consequently, the baffle can reduce patient arterial blood's in the feasible arterial blood is difficult for filling the protective sheath, reduces blood loss, the blood stain of easier clearance blood glucose monitor.

Optionally, the hemostix includes cylinder, pintle, needle, the needle is fixed and the intercommunication with the cylinder, the one end and the blood sampling window of needle can dismantle and be connected, the needle is kept away from the one end of needle and the pintle inserts the cylinder, pintle and the inside sliding connection of cylinder, the one end of pintle is fixed with the stopper, works as the pintle pushes the cylinder to extreme position, the stopper is kept away from the one end butt of needle with the cylinder.

Through adopting above-mentioned technical scheme, when medical personnel need gather arterial blood to the patient, medical personnel can communicate hemostix and blood sampling window, and blood sampling window and first pipe intercommunication, the arterial blood that the hemostix can pass through the blood sampling window at this moment carries out automatic filling to the position that the hemostix was preset, and consequently the automatic filling mode of hemostix has made things convenient for medical personnel's work.

Optionally, the injector device comprises an injection needle, an injection cylinder and an injection plug, wherein the injection needle is fixed and communicated with the injection cylinder, one end of the injection cylinder away from the injection needle is connected with the injection plug, and the injection plug is in sliding connection with the inside of the injection cylinder.

Through adopting above-mentioned technical scheme, after medical personnel control blood glucose monitor accomplishes blood glucose monitoring to the patient, arterial blood flows to the injection intracavity along the second pipe, flows to the injection tube by the injection intracavity again, injection tube and injection bolt sliding connection, consequently, the arterial blood of injection tube can be better the storage patient's arterial blood.

Optionally, the pressure sensing device includes presses valve and pressure detector, the one end that the second pipe was kept away from to the three-way valve is fixed and the intercommunication has the fourth pipe, the one end that the three-way valve was kept away from to the fourth pipe is fixed and the intercommunication has the valve of pressing, the one end that the fourth pipe was kept away from to the valve of pressing is fixed to the intercommunication has the fifth pipe, the one end that the valve was kept away from to the fifth pipe is fixed and the intercommunication with the pressure detector of pipeline form, and the one end that the pressure detector kept away from the fifth pipe is fixed and the intercommunication has the stop valve.

By adopting the technical scheme, the pressure sensing device monitors the arterial blood pressure of the patient in real time, and prevents the injury of the patient caused by overlarge arterial blood pressure.

Optionally, the pressing valve comprises a pressing handle and a spherical pressing cavity, and the pressing handle is fixed and communicated with the pressing cavity.

By adopting the technical scheme, after medical staff completes all operations on blood glucose monitoring of a patient, the medical staff opens the pressing valve, and physiological saline of the drip bottle is conveyed to the pressure detector along the third catheter to flush with the artery of the patient.

In summary, the present utility model includes at least one of the following beneficial technical effects:

1. because the blood glucose monitor is used by medical staff to monitor arterial blood of a patient, the blood glucose value of the arterial blood is monitored with higher accuracy than that of interstitial fluid or finger peripheral blood, so that the blood glucose value of the arterial blood of the patient is monitored by the blood glucose monitor more accurately.

2. The protective sleeve of the blood glucose monitor is provided with threads, and the sensing probe is in threaded connection with the first catheter, so that the sensing probe can extend into the artery of a patient to monitor blood glucose data;

3. the blood glucose monitor sets up the baffle, and the baffle can reduce patient's arterial blood make arterial blood be difficult for filling into in the protective sheath, reduces blood loss, and the blood stain of blood glucose monitor is cleared up to the relatively easy clearance.

Drawings

Fig. 1 is a schematic view of the overall structure in the present embodiment;

reference numerals illustrate: 1. a display; 101. a housing; 102. a display screen; 2. a blood glucose monitor; 201. a protective sleeve; 202. a baffle plate; 203. an inductive probe; 204. a connecting cylinder; 3. a first conduit; 4. a blood sampling window; 401. an A port; 402. a B port; 403. a C port; 5. a hemostix; 501. a pintle; 502. a needle cylinder; 503. a needle body; 504. a limiting block; 6. a second conduit; 7. a syringe; 701. a syringe; 702. an injection plug; 703. an injection needle; 8. a three-way valve; 801. a first port; 802. a second port; 803. a third port; 9. a fourth conduit; 10. pressing the valve; 1001. pressing the sleeve; 1002. pressing the handle; 1003. a pressing chamber; 11. a pressure sensing device; 1100. a pressure detector; 12. a fifth conduit; 13. a stop valve, 14, a third conduit, 15 and a dropping bottle.

Detailed Description

In order to make the objects, technical solutions and advantages of the present utility model more apparent, the present utility model will be further described in detail with reference to fig. 1 and the embodiment. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the utility model.

The embodiment of the utility model discloses an arterial blood sugar monitoring device in the technical field of medical and health instruments. Referring to fig. 1, an arterial blood glucose monitoring device includes a blood glucose monitor 2, a hemostix 5, a syringe 7, a pressure sensing device 11 and a drip bottle 15, the blood glucose monitor 2 stretches into a first conduit 3 connected with an artery of a patient, one end of the first conduit 3 far away from the artery of the patient is fixed and communicated with a three-way blood sampling window 4, one end of the blood sampling window 4 far away from the first conduit 3 is fixed and communicated with a second conduit 6, one end of the second conduit 6 far away from the blood sampling window 4 is communicated with a three-way valve 8, the three-way valve 8 comprises a first port 801, a second port 802 and a third port 803, the first port 801 is communicated with the second conduit 6, the syringe 7 is detachably fixed and communicated with the second port 802, an input end of the pressure sensing device 11 is communicated with the third port 803, an output end of the pressure sensing device 11 is communicated with a third conduit 14, the third conduit 14 is provided with a stop valve 13, one end of the third conduit 14 far away from the pressure sensing device 11 is communicated with the drip bottle 15, and the drip bottle 15 is used for supplementing physiological saline for the patient.

The blood glucose monitor 2 comprises a display 1 and a columnar sensing probe 203, one end of the sensing probe 203 is electrically connected and fixed with the display 1, a protective sleeve 201 is fixed on the periphery of the sensing probe 203 along the extending direction of the sensing probe, the protective sleeve 201 is used for preventing a patient from touching the sensing probe 203 to get an electric shock, threads are arranged on the outer side wall of the protective sleeve 201, one end of the protective sleeve 201 is fixedly connected with the display 1, one end of the protective sleeve 201, far away from the display 1, is fixedly provided with a baffle 202, one end, far away from the display 1, of the sensing probe 203 extends out of the baffle 202, and the baffle 202 is used for blocking arterial blood from being left in the protective sleeve 201; the first conduit 3 is fixed and communicated with a connecting tube 204, the inner wall of the connecting tube 204 is in threaded arrangement, the connecting tube 204 is in threaded connection with the protective sleeve 201, and when the protective sleeve 201 is screwed into the connecting tube 204 to the limit position, one end of the sensing probe 203, which is close to the first conduit 3, is positioned in the first conduit 3.

The display 1 comprises an elliptical shell 101 and a display screen 102, wherein the shell 101 is in a round-corner rectangular shape, the shell 101 is fixedly connected with the display screen 102, the display screen 102 is in a square shape, and the display screen 102 is used for displaying blood glucose concentration data.

The blood sampling window 4 includes an a port 401, a B port 402, and a C port 403, the first conduit 3 is fixed to and communicates with the a port 401, the blood sampling device 5 is detachably fixed to and communicates with the B port 402, and the C port 403 is fixed to and communicates with the second conduit 6.

The hemostix 5 comprises a syringe 502, a pintle 501 and a needle body 503, wherein one end of the needle body 503 is detachably fixed and communicated with the B port 402, one end of the needle body 503 far away from the B port 402 is fixed and communicated with the syringe 502, the pintle 501 stretches into the syringe 502, the pintle 501 is slidably connected with the inner wall of the syringe 502, a limiting block 504 is fixed at one end of the pintle 501, and when the pintle 501 is inserted into the syringe 502 to a limiting position, the limiting block 504 is abutted with one end of the syringe 502 far away from the needle body 503.

The syringe 7 comprises a spherical injection bolt 702, a syringe 701 and a syringe 703, the syringe 703 is fixed and communicated with the second port 802, one end of the syringe 703 away from the three-way valve 8 is communicated with the syringe 701, one end of the syringe 701 away from the syringe 703 is slidingly connected with the injection bolt 702, the injection bolt 702 extends into the syringe 701, and the syringe 701 is used for storing arterial blood of a human body and physiological saline of the drip bottle 15.

The pressure sensing device 11 comprises a pressing valve 10 and a pressure detector 1100, the third port 803 is communicated with a fourth conduit 9, one end of the fourth conduit 9 far away from the third port 803 is fixed and communicated with the pressing valve 10, the pressing valve 10 is used for flushing an arterial conduit of a patient, one end of the pressing valve 10 far away from the fourth conduit 9 is fixed and communicated with a fifth conduit 12, one end of the fifth conduit 12 far away from the pressing valve 10 is fixed and communicated with an input end of a pipeline-shaped pressure detector 1100, one end of the pressure detector 1100 far away from the sixth conduit is fixed and communicated with a third conduit 14, and the pressure detector 1100 is used for detecting blood pressure of the arterial conduit.

The pressing valve 10 includes a columnar pressing handle 1002 and a spherical pressing chamber 1003, a pressing sleeve 1001 is mounted on the periphery of the pressing handle 1002, the pressing sleeve 1001 is used for protecting the pressing handle 1002, and the pressing handle 1002 is fixed to and communicated with the pressing chamber 1003.

The implementation principle of the arterial blood glucose monitoring device provided by the embodiment of the utility model is as follows: after the medical staff communicates the first catheter 3 with the artery of the patient, arterial blood flows into the first catheter 3 and passes through the blood glucose monitor 2, and concentration data of arterial blood of the patient are acquired at the moment, because the blood glucose monitor 2 monitors arterial blood of the patient, and the data of arterial blood are more accurate.

After arterial blood sugar monitoring of a patient is completed by adopting the blood sugar monitor 2, a medical staff opens the stop valve 13, physiological saline stored in the drip bottle 15 flows to the three-way valve 8 along the third conduit 14 and is mixed with arterial blood of the patient, the physiological saline is mixed with arterial blood of the patient, the syringe 7 is connected with the three-way valve 8, the stop valve 13 is closed, the medical staff opens the three-way valve 8, the syringe 7 draws arterial mixed blood at the second port 802 of the three-way valve 8 and then closes the three-way valve 8, the hemostix 5 is inserted into the blood sampling window 4, after the arterial blood of the patient is automatically filled into the hemostix 5 to a preset position, the medical staff separates the hemostix 5 from the conduit, controls the three-way valve 8 to be opened, and injects the mixed arterial blood stored in the syringe 7 back to the arterial blood of the patient, after the injection is completed, the medical staff opens the stop valve 13 and presses the valve 10, and washes the arterial blood of the patient by using the physiological saline.

The foregoing description of the preferred embodiments of the utility model is not intended to limit the scope of the utility model in any way, including the abstract and drawings, in which case any feature disclosed in this specification (including abstract and drawings) may be replaced by alternative features serving the same, equivalent purpose, unless expressly stated otherwise. That is, each feature is one example only of a generic series of equivalent or similar features, unless expressly stated otherwise.

Claims

1. An arterial blood glucose monitoring device, characterized in that: including blood glucose monitor (2), blood collector (5), syringe (7), pressure sensor (11) and dropping bottle (15), blood glucose monitor (2) fixed intercommunication has first pipe (3), the one end of first pipe (3) is used for the intercommunication patient artery, the one end that communicates patient artery is fixed and the intercommunication has blood sampling window (4) is kept away from to first pipe (3), blood sampling window (4) can dismantle and communicate with blood collector (5), the one end that first pipe (3) was kept away from to blood sampling window (4) is fixed and the intercommunication has second pipe (6), the one end that blood sampling window (4) was kept away from to second pipe (6) is fixed and the intercommunication has three-way valve (8), three-way valve (8) can dismantle and the intercommunication with syringe (7), the one end that second pipe (6) was kept away from to three-way valve (8) is fixed and the intercommunication with pressure sensor (11), the one end that pressure sensor (11) kept away from second pipe (8) is fixed and the intercommunication has third pipe (14), third pipe (14) and third pipe (14) are kept away from one end (13) and are kept away from with fixed and the intercommunication of dropping bottle (13).

2. An arterial blood glucose monitoring device as claimed in claim 1, wherein: blood glucose monitor (2) are including display (1) and sensing probe (203), the one end of display (1) is fixed and the electricity is connected with the one end of sensing probe (203), sensing probe (203) are fixed with protective sheath (201), the one end and the display (1) fixed connection of protective sheath (201), extending direction setting along sensing probe (203) of protective sheath (201), the connecting cylinder (204) are connected with in detachable of the lateral wall of first pipe (3), connecting cylinder (204) and first pipe (3) intercommunication, the lateral wall screw thread setting of connecting cylinder (204), connecting cylinder (204) and protective sheath (201) threaded connection, when screw in to connecting cylinder (204) extreme position along the screw extending direction of connecting cylinder (204) of protective sheath (201), sensing probe (203) are located inside first pipe (3).

3. An arterial blood glucose monitoring device as claimed in claim 2, wherein: the display (1) comprises a shell (101) and a display screen (102), wherein the shell (101) is fixedly connected with the display screen (102), and the display screen (102) is used for displaying blood sugar concentration readings.

4. An arterial blood glucose monitoring device as claimed in claim 2, wherein: the protective sleeve (201) is fixedly connected with a baffle plate (202), the baffle plate (202) is fixedly connected with the inner side wall of the protective sleeve (201), the baffle plate (202) is fixedly connected with the side wall of the sensing probe (203), and one end part of the sensing probe (203) extends out of the baffle plate (202).

5. An arterial blood glucose monitoring device as claimed in claim 1, wherein: the hemostix comprises a needle cylinder (502), a needle plug (501) and a needle body (503), wherein the needle body (503) is fixed and communicated with the needle cylinder (502), one end of the needle body (503) is detachably connected with a blood sampling window (4), one end of the needle cylinder (502), far away from the needle body (503), is inserted into the needle cylinder (502) with the needle plug (501), the needle plug (501) is in sliding connection with the inside of the needle cylinder (502), a limiting block (504) is fixed at one end of the needle plug (501), and when the needle plug (501) is pushed into the needle cylinder (502) to a limiting position, the limiting block (504) is in butt joint with one end, far away from the needle body (503), of the needle cylinder (502).

6. An arterial blood glucose monitoring device as claimed in claim 1, wherein: the injector (7) device comprises an injection needle (703), an injection cylinder (701) and an injection plug (702), wherein the injection needle (703) is fixed and communicated with the injection cylinder (701), one end, far away from the injection needle (703), of the injection cylinder (701) is connected with the injection plug (702), and the injection plug (702) is in sliding connection with the inside of the injection cylinder (701).

7. An arterial blood glucose monitoring device as claimed in claim 1, wherein: the pressure sensing device (11) comprises a pressing valve (10) and a pressure detector (1100), one end of the three-way valve (8) away from the second conduit (6) is fixed and communicated with a fourth conduit (9), one end of the fourth conduit (9) away from the three-way valve (8) is fixed and communicated with the pressing valve (10), one end of the pressing valve (10) away from the fourth conduit (9) is fixedly communicated with a fifth conduit (12), one end of the fifth conduit (12) away from the pressing valve (10) is fixed and communicated with a pipeline-shaped pressure detector (1100), and one end of the pressure detector (1100) away from the fifth conduit (12) is fixed and communicated with a stop valve (13).

8. An arterial blood glucose monitoring device as claimed in claim 7, wherein: the pressing valve (10) comprises a pressing handle (1002) and a spherical pressing cavity (1003), and the pressing handle (1002) is fixed with and communicated with the pressing cavity (1003).